Free Trial

There has also been an article from.....>

MARKET TALK
MARKET TALK: There has also been an article from news.com.au passed around which
notes "A Canadian company has claimed it's found the cure for the deadly
coronavirus. Medicago, a biopharmaceutical company in Quebec City funded by the
Pentagon, said that it has produced a COVID-19 vaccine just 20 days after
receiving the coronavirus' genetic sequence, using a unique technology that they
soon hope to submit for FDA approval. The company's CEO, Bruce Clark, said his
company could produce as many as 10 million doses a month. If regulatory hurdles
can be cleared, Mr Clark said on Thursday, the vaccine could become available as
soon as November."
- Once again, I'm not sure that drives moves of the magnitude that we have seen.
- Thin market conditions and de-leveraging into the weekend is also being
touted.
- It is probably all a mix of the above, with the potential for the earlier
mentioned allocation flows also mixed in, although some of the moves are that
large that they are hard to justify.
MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com
MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.